학술논문
The Texas Community-Engagement Research Alliance Against COVID-19 in Disproportionately Affected Communities (TX CEAL) Consortium.
Document Type
Academic Journal
Author
Seguin-Fowler RA; Institute for Advancing Health through Agriculture, Texas A&M AgriLife, College Station, TX 77845, USA.; Amos C; Baylor College of Medicine, Houston, TX 77030, USA.; Beech BM; Department of Health Systems and Population Health Sciences, University of Houston, Houston, TX 77004, USA.; Ferrer RL; University of Texas Health Science Center at San Antonio, Long School of Medicine, San Antonio, TX 78229, USA.; McNeill L; Department of Health Disparities Research, Division of Cancer Prevention and Population Sciences, MD Anderson Cancer Center, Houston, TX 77079, USA.; Opusunju JJ; CAN DO Houston, Houston, TX 77012, USA.; Spence E; The University of North Texas Health Science Center at Fort Worth, Fort Worth, TX 76107, USA.; Thompson EL; Department of Biostatistics and Epidemiology, School of Public Health, The University of North Texas Health Science Center at Fort Worth, Fort Worth, TX 76107, USA.; Torres-Hostos LR; School of Social Work, The University of Texas Rio Grande Valley, Edinburg, TX 78539, USA.; Vishwanatha JK; Graduate School of Biomedical Sciences, The University of North Texas Health Science Center at Fort Worth, Fort Worth, TX 76107, USA.
Source
Publisher: Cambridge University Press Country of Publication: England NLM ID: 101689953 Publication Model: eCollection Cited Medium: Internet ISSN: 2059-8661 (Electronic) Linking ISSN: 20598661 NLM ISO Abbreviation: J Clin Transl Sci Subsets: PubMed not MEDLINE
Subject
Language
English
Abstract
The coronavirus disease 2019 (COVID-19) pandemic requires urgent implementation of effective community-engaged strategies to enhance education, awareness, and inclusion of underserved communities in prevention, mitigation, and treatment efforts. The Texas Community-Engagement Alliance Consortium was established with support from the United States' National Institutes of Health (NIH) to conduct community-engaged projects in selected geographic locations with a high proportion of medically underserved minority groups with a disproportionate burden of COVID-19 disease and hospitalizations. The purpose of this paper is to describe the development of the Consortium. The Consortium organized seven projects with focused activities to address COVID-19 clinical and vaccine trials in highly affected counties, as well as critical statewide efforts. Five Texas counties (Bexar, Dallas, Harris, Hidalgo, and Tarrant) were chosen by NIH because of high concentrations of underserved minority communities, existing community infrastructure, ongoing efforts against COVID-19, and disproportionate burden of COVID-19. Policies and practices can contribute to disparities in COVID-19 risk, morbidity, and mortality. Community engagement is an essential element for effective public health strategies in medically underserved minority areas. Working with partners, the Consortium will use community engagement strategies to address COVID-19 disparities.
Competing Interests: The authors have no conflicts of interest to declare.
(© The Author(s) 2022.)
Competing Interests: The authors have no conflicts of interest to declare.
(© The Author(s) 2022.)